FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 23, 2021
Source ID
10.1038/s41375-021-01177-6

Entities

People

  • Andrew J. Carroll
  • Cindy Wang
  • Donald Small
  • Elizabeth A. Raetz
  • Joanne M. Hilden
  • John A. Kairalla
  • Lia Gore
  • Meenakshi Devidas
  • Michael J. Borowitz
  • Mignon L. Loh
  • Naomi Winick
  • Nyla A. Heerema
  • Patrick Brown
  • Stephen P Hunger
  • Wanda L. Salzer
  • William L. Carroll
  • Zoann E. Dreyer

Organizations

  • Damon Runyon Cancer Research Foundation
  • Leukemia & Lymphoma Society
  • National Cancer Institute
  • St. Baldrick's Foundation
  • United States Department of Health and Human Services